Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVJF) Total Debt (2016 - 2025)

Historic Total Debt for Teva Pharmaceutical Industries (TEVJF) over the last 17 years, with Q4 2025 value amounting to $16.8 billion.

  • Teva Pharmaceutical Industries' Total Debt fell 549.4% to $16.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $16.8 billion, marking a year-over-year decrease of 549.4%. This contributed to the annual value of $16.8 billion for FY2025, which is 549.4% down from last year.
  • According to the latest figures from Q4 2025, Teva Pharmaceutical Industries' Total Debt is $16.8 billion, which was down 549.4% from $16.8 billion recorded in Q3 2025.
  • Teva Pharmaceutical Industries' Total Debt's 5-year high stood at $25.1 billion during Q2 2021, with a 5-year trough of $16.7 billion in Q1 2025.
  • Its 5-year average for Total Debt is $20.4 billion, with a median of $20.3 billion in 2023.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Total Debt crashed by 428.3% in 2021 and then crashed by 1523.62% in 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Total Debt (Quarter) stood at $23.0 billion in 2021, then decreased by 7.95% to $21.2 billion in 2022, then dropped by 6.5% to $19.8 billion in 2023, then dropped by 10.34% to $17.8 billion in 2024, then dropped by 5.49% to $16.8 billion in 2025.
  • Its Total Debt stands at $16.8 billion for Q4 2025, versus $16.8 billion for Q3 2025 and $17.2 billion for Q2 2025.